Gleevec Gets High Marks for Leukemia Treatment
New research suggests that Gleevec has transformed CML, a previously fatal leukemia, into a manageable chronic disease for many patients who take it.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.